Chemical Compound Review:
Azidopine 2-[(4-azidophenyl) carbonylamino]ethyl...
Synonyms:
AC1LCUW1, CHEMBL1993397, NSC-617999, NSC617999, NCI60_005410, ...
- Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells. Hu, Y.P., Henry-Toulmé, N., Robert, J. Eur. J. Cancer (1995)
- Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells. Rahman, A., Husain, S.R., Siddiqui, J., Verma, M., Agresti, M., Center, M., Safa, A.R., Glazer, R.I. J. Natl. Cancer Inst. (1992)
- Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit. Regulla, S., Schneider, T., Nastainczyk, W., Meyer, H.E., Hofmann, F. EMBO J. (1991)
- Reversal of anticancer multidrug resistance by the ardeemins. Chou, T.C., Depew, K.M., Zheng, Y.H., Safer, M.L., Chan, D., Helfrich, B., Zatorska, D., Zatorski, A., Bornmann, W., Danishefsky, S.J. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol. Christensen, J.G., LeBlanc, G.A. Cancer Res. (1996)
- Reversal of P-glycoprotein-mediated MDR by 5,7,3',4',5'-pentamethoxyflavone and SAR. Choi, C.H., Kim, J.H., Kim, S.H. Biochem. Biophys. Res. Commun. (2004)
- Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation. Hu, Y.P., Chapey, C., Robert, J. Cancer Lett. (1996)
- Relationship of VP-16 to the classical multidrug resistance phenotype. Sehested, M., Friche, E., Jensen, P.B., Demant, E.J. Cancer Res. (1992)
- Interaction of tamoxifen with the multidrug resistance P-glycoprotein. Callaghan, R., Higgins, C.F. Br. J. Cancer (1995)
- Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Zordan-Nudo, T., Ling, V., Liu, Z., Georges, E. Cancer Res. (1993)
- RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance. Perez-Victorias, F.J., Conseil, G., Munoz-Martinez, F., Perez-Victoria, J.M., Dayan, G., Marsaud, V., Castanys, S., Gamarro, F., Renoir, J.M., Di Pietro, A. Cell. Mol. Life Sci. (2003)
- P-glycoprotein-mediated transcellular transport of MDR-reversing agents. Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., Komano, T. FEBS Lett. (1993)
- Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins. Kino, K., Taguchi, Y., Yamada, K., Komano, T., Ueda, K. FEBS Lett. (1996)
- Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. Zhang, Y., Guo, X., Lin, E.T., Benet, L.Z. Drug Metab. Dispos. (1998)
- Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Choi, C.H., Kang, G., Min, Y.D. Planta Med. (2003)
- Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site. Kajiji, S., Talbot, F., Grizzuti, K., Van Dyke-Phillips, V., Agresti, M., Safa, A.R., Gros, P. Biochemistry (1993)
- Characterization of anthracenediones and their photoaffinity analogs. Chou, K.M., Krapcho, A.P., Horn, D., Hacker, M. Biochem. Pharmacol. (2002)
- Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. Hofmann, J., Gekeler, V., Ise, W., Noller, A., Mitterdorfer, J., Hofer, S., Utz, I., Gotwald, M., Boer, R., Glossmann, H. Biochem. Pharmacol. (1995)
- Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins. Yang, C.P., Mellado, W., Horwitz, S.B. Biochem. Pharmacol. (1988)
- On the mechanism of action of doxorubicin encapsulation in nanospheres for the reversal of multidrug resistance. Hu, Y.P., Jarillon, S., Dubernet, C., Couvreur, P., Robert, J. Cancer Chemother. Pharmacol. (1996)